SIRT6 and lung carcinoma: Further evidence suggests the tumor suppressor role of SIRT6 in other types of cancer such as hepatocellular carcinoma (HCC) [61], lung cancer [62] and nasopharyngeal carcinoma (NPC) [63], where SIRT6 has been found downregulated at gene level compared to normal tissues.